Association of pulmonary alveolar proteinosis and fibrosis: Patient with GATA2 deficiency

European Respiratory Journal

Volumn 48, Issue 5, 2016, Pages 1510-1514

  Ballerie, Alice ^a   Nimubona, Stanislas ^a   Meunier, Catherine ^a   Gutierrez, Francisco Llamas ^a   Desrues, Benoît ^a,b   Delaval, Philippe ^a,b   Jouneau, Stéphane ^a,b  

^a PONTCHAILLOU UNIVERSITY HOSPITAL   (France)

^b UNIVERSITÉ DE RENNES 1   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON MONOXIDE; TRANSCRIPTION FACTOR GATA 2; GATA2 PROTEIN, HUMAN;

ADULT; BONE MARROW BIOPSY; CASE REPORT; CAUCASIAN; CLINICAL EXAMINATION; COMPUTER ASSISTED TOMOGRAPHY; COUGHING; DIGITAL CLUBBING; DYSPNEA; EXON; FEMALE; FORCED VITAL CAPACITY; GATA2 DEFICIENCY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HISTOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; INTERSTITIAL LUNG DISEASE; LETTER; LUNG ALVEOLUS PROTEINOSIS; LUNG BIOPSY; LUNG FIBROSIS; LYMPHEDEMA; MEDICAL HISTORY; MYELODYSPLASTIC SYNDROME; NEW YORK HEART ASSOCIATION CLASS; PRIORITY JOURNAL; PROTEIN DEFICIENCY; SPIROMETRY; THORAX RADIOGRAPHY; TOTAL LUNG CAPACITY; COMPLICATION; DEFICIENCY; GENETICS; LUNG; MUTATION; PATHOLOGY; X-RAY COMPUTED TOMOGRAPHY;

ADULT; FEMALE; GATA2 TRANSCRIPTION FACTOR; HUMANS; LUNG; MUTATION; PULMONARY ALVEOLAR PROTEINOSIS; PULMONARY FIBROSIS; SPIROMETRY; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84994234499     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/13993003.00252-2016     Document Type: Letter

References (11)

1. Jouneau S, Kerjouan M, Briens E, et al. La proteinose alveolaire pulmonaire. [Pulmonary alveolar proteinosis.] Rev Mal Respir 2014; 31: 975-991.
2. Ishii H, Seymour JF, Tazawa R, et al. Secondary pulmonary alveolar proteinosis complicating myelodysplastic syndrome results in worsening of prognosis: a retrospective cohort study in Japan. BMC Pulm Med 2014; 14: 37.
3. Inoue Y, Trapnell BC, Tazawa R, et al. Characteristics of a large cohort of patients with autoimmune pulmonary alveolar proteinosis in Japan. Am J Respir Crit Care Med 2008; 177: 752-762.
4. Griese M, Zarbock R, Costabel U, et al. GATA2 deficiency in children and adults with severe pulmonary alveolar proteinosis and hematologic disorders. BMC Pulm Med 2015; 15: 87.
5. Marchand-Adam S, Diot B, Magro P, et al. Pulmonary alveolar proteinosis revealing a telomerase disease. Am J Respir Crit Care Med 2013; 188: 402-404.
6. Luisetti M, Bruno P, Kadija Z, et al. Relationship between diffuse pulmonary fibrosis, alveolar proteinosis, and granulocyte-macrophage colony stimulating factor autoantibodies. Respir Care 2011; 56: 1608-1610.
7. Ishii H, Tazawa R, Kaneko C, et al. Clinical features of secondary pulmonary alveolar proteinosis: pre-mortem cases in Japan. Eur Respir J 2011; 37: 465-468.
8. Ishii H, Trapnell BC, Tazawa R, et al. Comparative study of high-resolution CT findings between autoimmune and secondary pulmonary alveolar proteinosis. Chest 2009; 136: 1348-1355.
9. Briens E, Delaval P, Mairesse MP, et al. Lipoproteinose alveolaire pulmonaire. [Pulmonary alveolar proteinosis.] Rev Mal Respir 2002; 19: 166-182.
10. Spinner MA, Sanchez LA, Hsu AP, et al. GATA2 deficiency: a protean disorder of hematopoiesis, lymphatics, and immunity. Blood 2014; 123: 809-821.
11. Cuellar-Rodriguez J, Gea-Banacloche J, Freeman AF, et al. Successful allogeneic hematopoietic stem cell transplantation for GATA2 deficiency. Blood 2011; 118: 3715-3720.